Retrospective Safety Survey In Patients Included In NV1FGF Clinical Trials

NCT01135797 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 164

Last updated 2011-04-28

No results posted yet for this study

Summary

The objective of this study is to collect retrospectively long term safety data in patients who have participated in the previous phase I-II trials conducted with the compound.

Conditions

  • Peripheral Arterial Occlusive Disease

Sponsors & Collaborators

Principal Investigators

  • Clinical Sciences & Operations · Sanofi

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States
  • Belgium
  • France
  • Germany
  • Italy
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01135797 on ClinicalTrials.gov